Seqanswers Leaderboard Ad
Collapse
Announcement
Collapse
No announcement yet.
X
-
day 0
sample 1 - untreated
day 3
sample 2 - treated with "A"
sample 3 - treated with "B"
sample 4 - treated with "C"
day 6
sample 5 - treated with "A"
sample 6 - treated with "B"
sample 7 - treated with "C"
day 9
sample 8 - treated with "A"
sample 9 - treated with "B"
sample 10 - treated with "C"
They want to see DE across time as well as across treatments. I am just a bioinformatician. Some body else did the experiments and I have the rnaSeq data for it. This is all I have been told.
Ashu
Originally posted by Simon Anders View Post45 comparisons still would only take an hour or so. However, my feeling is that you are doing something fundamentally wrong if you are comparing pairs of samples, rather than pairs of conditions or time points.
Maybe explain a bit more about the biology of your experiment.
Comment
-
Originally posted by ashuchawla View Postday 0
sample 1 - untreated
day 3
sample 2 - treated with "A"
sample 3 - treated with "B"
sample 4 - treated with "C"
day 6
sample 5 - treated with "A"
sample 6 - treated with "B"
sample 7 - treated with "C"
day 9
sample 8 - treated with "A"
sample 9 - treated with "B"
sample 10 - treated with "C"
They want to see DE across time as well as across treatments. I am just a bioinformatician. Some body else did the experiments and I have the rnaSeq data for it. This is all I have been told.
Ashu
I think you need a "untreated" control for every time point, or the time will be a extra variable.
Comment
-
I think I have found a solution. CuffDiff actually does output a count of each feature (genes.count_tracking, cds.count_tracking, etc). I ran cuffDiff with each sample treated as a separate treatment, c.f. different samples from the same treatment being identified as replicates using the -L/--labels feature. This gave me count data for each feature in each sample.
Comment
Latest Articles
Collapse
-
by seqadmin
Many organizations study rare diseases, but few have a mission as impactful as Rady Children’s Institute for Genomic Medicine (RCIGM). “We are all about changing outcomes for children,” explained Dr. Stephen Kingsmore, President and CEO of the group. The institute’s initial goal was to provide rapid diagnoses for critically ill children and shorten their diagnostic odyssey, a term used to describe the long and arduous process it takes patients to obtain an accurate...-
Channel: Articles
12-16-2024, 07:57 AM -
-
by seqadmin
Innovations in next-generation sequencing technologies and techniques are driving more precise and comprehensive exploration of complex biological systems. Current advancements include improved accessibility for long-read sequencing and significant progress in single-cell and 3D genomics. This article explores some of the most impactful developments in the field over the past year.
Long-Read Sequencing
Long-read sequencing has seen remarkable advancements,...-
Channel: Articles
12-02-2024, 01:49 PM -
ad_right_rmr
Collapse
News
Collapse
Topics | Statistics | Last Post | ||
---|---|---|---|---|
Started by seqadmin, 12-17-2024, 10:28 AM
|
0 responses
23 views
0 likes
|
Last Post
by seqadmin
12-17-2024, 10:28 AM
|
||
Started by seqadmin, 12-13-2024, 08:24 AM
|
0 responses
42 views
0 likes
|
Last Post
by seqadmin
12-13-2024, 08:24 AM
|
||
Started by seqadmin, 12-12-2024, 07:41 AM
|
0 responses
28 views
0 likes
|
Last Post
by seqadmin
12-12-2024, 07:41 AM
|
||
Started by seqadmin, 12-11-2024, 07:45 AM
|
0 responses
42 views
0 likes
|
Last Post
by seqadmin
12-11-2024, 07:45 AM
|
Comment